Basel Medical Group Ltd has regained compliance with the Nasdaq minimum bid price requirement. The company received notification from Nasdaq confirming that its ordinary shares maintained a closing bid price of at least $1.00 per share for the last 10 consecutive business days, from June 23, 2026 to July 7, 2026. This follows a January 22, 2026 notice from Nasdaq that the shares had failed to meet the $1.00 minimum bid price over the prior 30 consecutive business days. With the recent price recovery, the company now satisfies Listing Rule 5550(a)(2).
Basel Medical Group Ltd Ordinary SharesCompany regained compliance with Nasdaq minimum bid price requirement, avoiding delisting risk.